Compare · ASXC vs MDLN
ASXC vs MDLN
Side-by-side comparison of Asensus Surgical Inc. (ASXC) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASXC and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 219.6x ASXC ($201.1M).
- MDLN has hit the wire 20 times in the past 4 weeks while ASXC has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 3 for ASXC).
- Company
- Asensus Surgical Inc.
- Medline Inc.
- Price
- $0.35+0.84%
- $33.60-2.50%
- Market cap
- $201.1M
- $44.15B
- 1M return
- -
- -19.90%
- 1Y return
- -
- -17.55%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- AMEX
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 20
- Recent ratings
- 3
- 25
Asensus Surgical Inc.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.
Latest ASXC
- SEC Form 15-12G filed by Asensus Surgical Inc.
- SEC Form EFFECT filed by Asensus Surgical Inc.
- SEC Form EFFECT filed by Asensus Surgical Inc.
- SEC Form EFFECT filed by Asensus Surgical Inc.
- SEC Form EFFECT filed by Asensus Surgical Inc.
- SEC Form EFFECT filed by Asensus Surgical Inc.
- SEC Form S-8 POS filed by Asensus Surgical Inc.
- SEC Form S-8 POS filed by Asensus Surgical Inc.
- SEC Form S-8 POS filed by Asensus Surgical Inc.
- SEC Form S-8 POS filed by Asensus Surgical Inc.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)